Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
about
The crystal structure of the endothelial protein C receptor and a bound phospholipidImmune privilege: keeping an eye on natural killer T cells.Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity.Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.Stimulation of natural killer T cells by glycolipidsClinical application of NKT cell assays to the prediction of type 1 diabetes.Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancerActivation of CD11b+ Kupffer cells/macrophages as a common cause for exacerbation of TNF/Fas-ligand-dependent hepatitis in hypercholesterolemic mice.New mechanisms for vascular control of inflammation mediated by natural anticoagulant proteins.Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy.Sulfatide-mediated activation of type II natural killer T cells prevents hepatic ischemic reperfusion injury in mice.Protein C pathway in sepsis.Expression of CD1d in human scalp skin and hair follicles: hair cycle related alterations.Elevated proportion of natural killer T cells in periodontitis lesions: a common feature of chronic inflammatory diseases.Going both ways: immune regulation via CD1d-dependent NKT cells.Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.Immune problems in central nervous system cell therapy.Endothelial protein C receptor is overexpressed in rheumatoid arthritic (RA) synovium and mediates the anti-inflammatory effects of activated protein C in RA monocytesA privileged view of NKT cells and peripheral tolerance through the eye.Natural killer T cell activation inhibits hepatitis B virus replication in vivo.Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.The role of T cells in periodontal disease: homeostasis and autoimmunity.Food components and the immune system: from tonic agents to allergens.Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responsesalpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malariaSynthesis of a novel alpha-galactosyl ceramide haptenated-lipid antigen, a useful tool in demonstrating the involvement of iNKT cells in the production of antilipid antibodies.Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation.The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction.Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.Synthesis and biological activity of alpha-galactosyl ceramide KRN7000 and galactosyl (alpha1-->2) galactosyl ceramide.NK cells are required for costimulatory blockade induced tolerance to vascularized allograftsSynthesis and biological activity of alpha-glucosyl C24:0 and C20:2 ceramides.Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli.Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation.Failure of rIL-12 administration to inhibit established IgE responses in vivo is associated with enhanced IL-4 synthesis by non-B/non-T cells.
P2860
Q27639046-0072C4F5-CA1B-4C28-A609-EE159967C5EDQ30050558-6A128206-9B9C-4AB7-A782-C2D51F8AFC52Q30374900-BA906CC4-25D4-4B35-8F9C-62CAE3BAAEF9Q33552034-7B039371-BDF1-4E1B-926A-3E11C83B354AQ33599059-F9E13E1E-17A9-4F7A-B32E-246232E28C7CQ34470637-1070F212-ED93-41AE-B3BA-0CEC55BAA820Q34565029-28D02496-70A2-40E0-B34F-8EE34645709CQ34570817-94BCED86-FA34-4774-8ECD-86386487B897Q34809827-03FCACFF-40DE-421B-8105-6AE2CCB48793Q34993205-2155DEB1-CC9A-4B45-9B43-D5FAB239EA5FQ35043531-C0082B57-89CB-48F0-83AA-297F5DF4EC5FQ35055016-92C1E30C-FA61-4E93-A96F-A223B2EA4D54Q35588928-5FD6ED1C-45FF-40D6-AD72-491ED2E37427Q35841986-D903DD9A-2B62-4DF5-AF64-E6EEAAC81942Q35951531-4D55D3BC-D2DF-4163-8FA5-FBEE19575F08Q35973205-79333D35-EFB0-427F-86D7-B684E3D9676DQ36045396-BEAA73EF-C23D-4733-9D6D-B4A47DBE9FB3Q36171858-E7B2E4F5-20F9-463C-92BA-D80A8250F93AQ36194819-25BBC0E6-36B4-465F-9E27-73EDAB2AD2F3Q36368956-2A3679DD-1764-41FB-8A06-866D0B99D5A5Q36369797-3846ECDF-839F-400B-8E6F-7A564618B701Q36703937-9787ED68-5A70-49A9-A159-11D7F37ACCE8Q36850687-5C5D9780-0351-407E-8EDD-B607166618F4Q37002932-B43074FE-41B2-4CAF-8251-0E83D3C912B6Q37229005-6127D4A2-6C30-495C-928E-8590D45D5834Q37322551-CED53CED-5EE4-46A2-9962-977B136CFFF5Q37383985-B7CA2D6F-4834-4687-8277-F9E94897AE1DQ38786934-05432586-90CA-4DE9-B3AA-E8289BEB6BAEQ39196835-0272591A-8957-4FFB-9E52-6E200340E3B1Q39517775-072AAA0E-C9CA-4FED-ACE5-C4D4FEF35FE0Q39841856-70C4B4A5-7EA4-4236-9657-5816F6A49423Q42016732-BF12EC59-54AD-4622-B84A-D5B4A68EFC03Q42172806-4845F2D1-CF85-4E14-A1C1-6AAD57B522DEQ42267314-7F06512F-C780-441B-8396-8E3783FCE91CQ42669213-6F1860D0-6A6B-46D8-8D29-7F9FBC84A421Q53770466-68C4DA7D-6488-40A5-9A2F-D6B7BA44FC2A
P2860
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
@ast
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
@en
type
label
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
@ast
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
@en
prefLabel
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
@ast
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice.
@en
P2093
P2860
P1476
Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice
@en
P2093
P2860
P356
10.1111/J.1600-065X.1999.TB01304.X
P50
P577
1999-06-01T00:00:00Z